NCT04510376 |
Allergy Potential of Omeza Collagen Matrix in Human Subjects Using the Skin Prick Method |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510363 |
Optic Nerve Sheath Diameter Carotid Duplex and Transcranial Duplex as a Prognostic Factor |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510350 |
Investigation of Novel Immunological Biomarkers by Mass Cytometry in Patients With Early Multiple Sclerosis CISCO |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510337 |
Does Adding Magnesium Sulphate to Low Dose Rocuronium Affects Depth of Blockade |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510324 |
Plant-Based Meat vs Animal Red Meat Trial |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510311 |
Imaging Properties of PET Radiotracer 18F3F-PHPG in Patients With Neuroendocrine Tumors |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510298 |
A Study of the Safety PK and Exploratory Efficacy of SP-624 in Acutely Psychotic Adult Subjects With Schizophrenia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510285 |
A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2 Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510272 |
Aloud Real-time Reading of ICU Diaries for Prevention of Negative Post-ICU Psychological Outcomes |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510259 |
Selective Trunk Brachial Plexus Block |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510246 |
Link Hepatitis C Notifications to Treatment in Tasmania |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510233 |
Ivermectin Nasal Spray for COVID19 Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510220 |
9-month Study to Assess the Efficacy of Ofatumumab on Microglia in Patients With Relapsing Forms of Multiple Sclerosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510207 |
A Study to Evaluate The Efficacy Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines Vero Cell in Healthy Population Aged 18 Years Old and Above |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510194 |
COVID-OUT Early Outpatient Treatment for SARS-CoV-2 Infection COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510181 |
Effect of an Amino-Acid-Based Blend on Human Growth Hormone hGH and Fibromyalgia FM Symptoms |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510168 |
Accelerated Non-Atherosclerotic Brain Arterial Aging Relationship to Alzheimers Disease |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510155 |
Liver Glycogen Dynamics |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510142 |
Questionnaire Followup Study Sonia 2 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510129 |
A Multicenter Cancer Biospecimen Collection Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510116 |
Adults In The Making Prevention Trial |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510103 |
A Controlled Clinical Study of 2 Different Moisturizers for the Relief of Dry Skin |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510090 |
Evaluate the Safety Tolerability and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510077 |
SmartQuit Program for Smoking Cessation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510064 |
PD-1 Antibody Combined With Modified FLOT Regimen in the Treatment of Unresectable Locally Advanced or Limited Metastatic Gastric Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510051 |
CAR T Cells After Lymphodepletion for the Treatment of IL13Rα2 Positive Recurrent or Refractory Brain Tumors in Children |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510025 |
Capturing MultiORgan Effects of COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04510012 |
Characterizing the Immune Response and Neuronal Damage in COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509999 |
Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509986 |
GlobalSurg-CovidSurg Week |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509973 |
Higher vs Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509960 |
Different Ways of Airway Management in Elective Minor Surgeries in Geriatric Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509947 |
A Study of Ad26COV2S in Adults COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509934 |
The Effect of Connective Tissue Manipulation on General Health and Emotional Status in Women With Primary Dysmenorrhea |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509921 |
Adjustment of Asthma Treatment in Children Based on an Indirect Hyperresponsiveness Test |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509908 |
Eating and Physical Activity Patterns of the Population Working in the Uruguayan State Electrical Company |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509895 |
Minimally Invasive Calcaneal Fracture Fixation vs Standard Lateral Approach |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509882 |
Bear Bile Pill as add-on the Treatment of MDD |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509869 |
Outcome of Varicocelectomy on Normal Semen in Patients Complaining of Orchialgia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509856 |
Teach-Back Educational Method On Diabetes Knowledge Level |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509843 |
Impact of Socioeconomic Status and Oral Hygiene Practice on Periodontal Health of Egyptian Adults |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509830 |
Efficacy of Hip Strengthening on Dynamic Knee Stability Disability and Gait in Knee Osteoarthritis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509817 |
Acupuncture for Oligomenorrhea Due to Polycystic Ovary Syndrome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509804 |
Target Gene Sequencing for Advanced Stage Relapsed or Refractory Natural KillerT-cell Lymphoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509791 |
MELD-ATG Phase II Dose Ranging Efficacy Study of Anti-thymocyte Globulin ATG Within 6 Weeks of Diagnosis of Type 1 Diabetes T1D |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509778 |
Develop a Psychosis Risk Calculator for Chinese Mental Health Servises |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509765 |
A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509752 |
Dysphagia Management During COVID-19 Pandemic |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509739 |
Effect of Music Intervention on Infants Brainstem Encoding of Speech |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509726 |
EBV Specific Cytokine Secreting TCR-T Cells in the Treatment of EBV-Positive MetastaticRefractory Nasopharyngeal Carcinoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509713 |
Canine COVID-19 Detection |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509700 |
Rollover Study to Provide Continued Treatment for Participants With B-Cell Malignancies Previously Enrolled in Studies of Parsaclisib INCB050465 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509687 |
Training Endoscopists to Perform On-site Rapid Cytological Evaluation for EUS-FNA of Solid Pancreatic Lesions |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509674 |
EMPACT-MI A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack Myocardial Infarction |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509661 |
Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow Limitation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509648 |
Adjuvant Regional Nodal Radiation Therapy for One Week in Breast Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509635 |
Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509622 |
A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine LDAC Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia AML |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509609 |
Clinical Determinants of Disease Progression in Patients With Limb Girdle Muscular Distrophy Type 2E |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509596 |
DZD1516 in Combination With Trastuzumab and Capecitabine or in Combination With T-DM1 in Patients With Metastatic HER2 Positive Breast Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509583 |
The Role of Micro Nutrient Supplement in Improvement of the Sperm DNA Fragmentation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509570 |
A Prospective Retrospective Study on Ectopic Lymphoid-like Structures in Chronic Skins of Autoimmune Bullous Diseases |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509557 |
177LuLudotadipep Treatment in Patients With Metastatic Castration-resistant Prostate Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509544 |
Satisfaction and Preferences About Motor Rehabilitation in People With Cerebral Palsy ESPaCe a French Survey |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509531 |
Building Resilience in Cyberbullying Victims |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509518 |
Effectiveness of Selected Physical Therapy Exercise Program and Transcutaneous Electrical Nerve Stimulation on Patients With Pudendal Neuralgia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509505 |
Effect of Waterpipe Smoking on Periodontal Health |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509492 |
Role of EUS in Detection of Liver Metastasis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509479 |
National Tunisian Registry of Valvulopathies NATURE-VALVE |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509466 |
Clinical Study of Liposomal Mitoxantrone Hydrochloride Injection Combined With Pegaspargase in the Treatment of NKTCL |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509453 |
McGRATH vs Macintosh Laryngoscopy Comparison in LMA Insertion |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509440 |
Efficacy of Neural Prolotherapy for Treatment of Anserine Bursitis NPCAB |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509427 |
Exercise and Posture in Individuals With Osteoporosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509414 |
Intranasal Dexmedetomidine for Deep-sedated Pediatric Dental Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509401 |
Effects of High Dose of Vitamin B6 With Magnesium in Children With Autism Spectrum Disorder |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509388 |
Effects of Drink Composition on the Appearance of Ingested Water in Body Fluids |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509375 |
Near-Infrared Spectroscopy and Cranial Doppler in Premature Newborns With Anemia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509362 |
An 8-Day Initiation of Advanced Hybrid Closed Loop System In Children and Adolescents |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509349 |
Alternating Current Stimulation for Essential Tremor |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509336 |
Orphenadrine Versus Baclofen in Treatment of Muscle Cramps in Cirrhotic Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509323 |
Clinical Study of Huperzine A in the Treatment of Patients With Hypertensive Cerebral Hemorrhage |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509310 |
Active Bodysuits for Adult Degenerative Scoliosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509297 |
Resistance Training and Milk Supplementation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509284 |
Analgesic Effect of Resistance Training for Breast Cancer Survivors |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509271 |
Study on Novel Peripheral Blood Diagnostic Biomarkers for MCI Due to Alzheimers Disease |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509258 |
Effectiveness of N-acetyl Cysteine Acetyl L- Carnitine and Medicated Paraffin Oil in Aluminium Phosphide Poisoning |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509245 |
The Effects of a Novel Lifestyle Intervention Program on Insulin Sensitivity in Type 2 Diabetes |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509232 |
Assessing Parental Acceptance to Silver Diamine Fluoride Staining Before and After Masking the Colour With Glass Ionomer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509219 |
Methylprednisolone Pulse Therapy for Coronary Artery Dilatation or Aneurysm Formation in Kawasaki Disease |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509206 |
Virtual Teaching Kitchen |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509193 |
A Study Using Electronic Health Information to Learn About Rivaroxaban Compared to Warfarin in Participants With Non-valvular Atrial Fibrillation NVAF and Diabetes |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509180 |
Comparison of Treatment Outcomes Between Convergent Procedure and Catheter Ablation for Persistent and Longstanding Persistent Atrial Fibrillation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509167 |
Pilot Study of Neoantigen Peptides for the Treatment of Neoplasms |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509154 |
Effectiveness of the Multicomponent Therapy in Chronic Pain Through The Use of Smartphones |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509141 |
Acupuncture as Migraine Prophylaxis in Reducing Frequency Duration and Intensity of Migraine With Minimum Acupoint Seen up to Eight Weeks From Baseline |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509128 |
Ultrasonographic Evaluation of Diaphragm and Quadriceps in Chronic Obstructive Pulmonary Disease COPD Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509115 |
Variation in Opioid Prescribing and Use for Acute Pain in Diverse Populations |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509102 |
Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509089 |
Establishing Correlation Between Non-invasive Pulmonary Blood Pressure Readings and Swan-Ganz Results |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509076 |
PrEP iT Mobile App Intervention |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509063 |
Investigating Public Enthusiasm for Mammography Screening in Denmark |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509050 |
Study to Evaluate Biological Clinical Effects of Significantly Corrected CFTR Function in Infants Young Children |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509037 |
Evaluation of Breast Reduction Techniques |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509024 |
Incidental Auditory Category Training for Language Learning |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04509011 |
Autofluorescence vs Clinical Assessment of Parathyroid Glands During Thyroid Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508998 |
PRIZE ET Sub-Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508985 |
The McGill RAAS-COVID-19 Trial |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508972 |
The VOICE-COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508959 |
The McMaster Multi-Regional COVID-19 Hospital Case Registry |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508946 |
Triple Therapy in Septic Shock Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508933 |
Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and TypicalARDS Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508920 |
A Survey to Assess Effects of Covid-19 on Cardiovascular Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508907 |
A Study to Evaluate Preemptive Therapy in Hepatitis C HCV Organ Transplant Recipients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508894 |
Ketamine Versus Dexmedetomidine in Supraclavicular Brachial Plexus Block |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508881 |
Intraluminal Stenting Versus External Ligation of Ahmed Glaucoma Valve |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508868 |
Treatment of Depressive Symptoms in Older Individuals in Isolation During Covid-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508855 |
Management of Atrial Fibrillation in Patients With Cancer MAFIC Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508842 |
CD19CD22-Dual-STAR-T for Patients With B Cell Acute LeukemiaB-ALL |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508829 |
Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508816 |
Anti-EGFR Therapy Plus IMRT Concurrent Chemoradiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508803 |
Combination of HX008 And Niraparib in GErm-line-mutAted Metastatic Breast Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508790 |
Leflunomide Pomalidomide and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508777 |
COVID SAFE COVID-19 Screening Assessment for Exposure |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508764 |
Implementation of the Families Accelerating Cascade Testing Toolkit FACTT for Hereditary Breast and Ovarian Cancer and Lynch Syndrome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508751 |
PED NEONAT 20-000599 Fetal Body Composition |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508738 |
Effects of Combined Interventions to Optimize Recovery During High-intensity Exercises in Healthy Adults |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508725 |
Serial Ultrasound in Metastatic Renal Cell Carcinoma mRCC |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508712 |
Long-term Outcomes in Patients With COVID-19 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508699 |
Semantic Learning Deficits in School Age Children with Developmental Language Disorder |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508686 |
Combination of Metronomic Capecitabine With Camrelizumab for Treatment of Refractory Solid Tumor Trial Cohort 1 |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508673 |
Impact of GH Measurements on GHD Diagnosis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508660 |
CGB-400 for the Reduction of Facial Redness |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508647 |
Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508634 |
Treating Obese PCOS Patients With LSG vs Met |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508621 |
A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508608 |
Scintigraphic Evaluation of Contractile and Coronary Reserve in Patients With Ischemic Cardiomyopathy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508595 |
The RestEaze Ambulatory Sleep Monitor for Detection of Leg Movements During Sleep in Adults and Children With a Sleep Disturbance |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508582 |
Cardiac and Immune Cell Function in Preeclampsia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508569 |
Evaluation of Big Decisions in Three South Texas School Districts |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508556 |
Performance Assessment of SARS-CoV-2 Detection Breath Biopsy - SARS-CoV-2 Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508543 |
Assessing Patient-provider Interactions During the Preoperative Anesthesia Consult |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508530 |
Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome PANSPANDAS |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508517 |
Brain White Matter Injury in Late Preterm Infants |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508504 |
PENG Block for Arthroscopic Hip Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508491 |
Cognitive Function in Patients With Persisted Atrial Fibrillation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508478 |
Exercise Training to Atrial Fibrillation |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508465 |
Persistent Postoperative Pain After Major Emergency Abdominal Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508452 |
A Phase II Prospective Trial of mXELOXIRI Reintroduction for mCRC |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508439 |
Effect of the Use of Anticoagulant Therapy During Hospitalization and Discharge in Patients With COVID-19 Infection |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508426 |
Single-dose AME Study With 14CAR882 in Healthy Male Subjects |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508413 |
A Clinical Study to Assess the Effects of KB295 in Patients With Ulcerative Colitis UC on Gut Microbiota Structure and Function |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508400 |
Fosaprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508387 |
The Effects of CO2 Pneumoperitoneum at Different Temperature in Laparoscopic Surgery |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508374 |
Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508361 |
Test-retest Reliability for Fatigue Assessment Scale Short Form 6 Dimension and Kings Sarcoidosis Questionnaire |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508348 |
Clinical Trial to Decrease Length of Stay in Infants With Neonatal Abstinence Syndrome With an Exclusive Human Milk Diet |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508335 |
Trial of device that is not approved or cleared by the US FDA |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508322 |
Treatment of Class II Malocclusion With Excessive Overjet |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508309 |
Phase 3 Trial of a Bivalent HPV Vaccine Cecolin in Young Girls |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508296 |
The Effect pf Goal-directed De-escalation in ARDS on Organ Function and Mortality |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508283 |
Fiber Intake Among Children in Relation to Milk Type Gastrointestinal Symptoms and Iron Status a Cross-sectional Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508270 |
Significance of Early Mobilization After VATS-L |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508257 |
The Effect of a New Infant Formula on Growth and Cognition in Healthy Term Infants |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508244 |
Beta Blocker Use In Traumatic Brain Injury Based On The High-Sensitive Troponin T Status |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508231 |
Metabolic Consequences of Cross-sex Hormonal Treatment |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508218 |
Protein Supplementation and Exercise Training in Burn Patients |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508205 |
CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508192 |
Copenhagen Adduction Exercise vs an Adductor Squeeze Exercise |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508179 |
A Phase 1 SAD and MAD Study of the Safety Tolerability and PK of 7HP349 in Normal Healthy Male Subjects |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508166 |
Towards a Post-exposition Pharmacological Prophylaxis for Post-traumatic Stress Disorder |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508153 |
Pelvic Floor Muscle Training With a Digital Therapeutic Device to Standard Exercises for Stress Urinary Incontinence |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508140 |
Study of BO-112 With Pembrolizumab for Colorectal or GastricGEJ Cancer With Liver Metastasis |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508127 |
A Feasibility Study to Investigate the Dynamic Brain Imaging in Patients Following SCS- DRG |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508114 |
Technology-assisted Index on Improving Hand Hygiene of Registered Nurses |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508101 |
Suction Drainage in the Management of Peri-operative Bleeding in Total and Unicomcompartmental Knee Arthroplasty |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508088 |
Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508075 |
Efficacy Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508062 |
Effects of the Addition of Uterosacral Ligament Plication to Pectopexy Operation on Anatomical and Subjective Symptoms |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508049 |
A Study to Evaluate Renal Fibrosis Using MRI Techniques |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508036 |
Ductus Arteriosus Closure and D-Dimer and Fibrinogen Levels |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508023 |
A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events Hospitalization and Death in Medically Ill Outpatients With Acute Symptomatic Coronavirus Disease 2019 COVID-19 Infection |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04508010 |
Comparison of IVR and CATI Surveys in Bangladesh |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507997 |
Angelman Syndrome Natural History Study |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507984 |
Universal Familial Hypercholesterolemia Screening in Children |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507971 |
Effects of MET-3 and MET-5 on Gut Microbiome and Metabolic Function in Men and Women With Hypertriglyceridemia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507958 |
Electronic Stethoscope Use During Intubation in Full Personal Protective Equipment |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507945 |
Stablishment of Prevention and Treatment System for Intestinal Dysfunction |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507932 |
Characterizing Inflammatory Bowel Disease With 68Ga-FAPI PETCT |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507919 |
Managed Access Program Cohort Treatment Plan CTMT212X2002I to Provide Access to Trametinib and Dabrafenib Combination Therapy for Patients With BRAF V600 Mutation-positive Advanced Non-Small Cell Lung Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507906 |
Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507893 |
Comparison Between Positive and Negative COVID-19 Pneumonia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507880 |
A 2-Year Prospective Follow-up Study of the Global Unite Reverse Fracture Shoulder System for Proximal Humerus Fractures |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507867 |
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507854 |
Return to Performance Criteria Following Shoulder Instability Surgery in the Athlete |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507841 |
Niraparib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507828 |
Combined Deep Inspiration Breath Hold DIBH-Expiration Planning Technique in Patients with Lung Tumors in Close Proximity to the Chest Wall |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507815 |
tDCS and Cognitive Training for Mild Cognitive Impairment and Alzheimers Dementia |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507802 |
Helmet vs Face Mask in Patients With Acute Respiratory Distress Syndrome |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507789 |
Exercise Therapy During Radiotherapy |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|
NCT04507776 |
Study To Evaluate The Efficacy And Long-Term Adherence Of SpondyloarthropathiesSpA Patients On Enbrel |
Identification |
Status |
Sponsor Collaborators |
Oversight |
Description |
Conditions |
Arms Interventions |
Outcomes |
Eligibility |
Contacts Locations |
References |
IPD Sharing Statement |
View
|